{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:35:01Z","timestamp":1784194501131,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2012.01.054","type":"journal-article","created":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T22:53:35Z","timestamp":1328050415000},"page":"2329-2335","source":"Crossref","is-referenced-by-count":22,"title":["Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)"],"prefix":"10.1016","volume":"30","author":[{"given":"Akiko","family":"Kikukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masateru","family":"Akechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadao","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Namazue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Fuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyokazu","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeharu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"81","key":"10.1016\/j.vaccine.2012.01.054_bib0005","first-page":"325","volume":"34\/35","author":"WHO","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"issue":"August (9)","key":"10.1016\/j.vaccine.2012.01.054_bib0010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis\u2014within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.01.054_bib0015","series-title":"Recommendations for Japanese Encephalitis Vaccine (inactivated) for human use. Expert Committee on Biological Standardization, Geneva, October 8\u201312","author":"WHO","year":"2007"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.01.054_bib0020","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jnnp.59.3.316","article-title":"Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains)","volume":"59","author":"Ohtaki","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2012.01.054_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0887-8994(92)90036-X","article-title":"Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination","volume":"8","author":"Ohtaki","year":"1992","journal-title":"Pediatr Neurol"},{"issue":"80","key":"10.1016\/j.vaccine.2012.01.054_bib0030","first-page":"241","volume":"28","author":"WHO","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.01.054_bib0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/erv.11.7","article-title":"New Japanese encephalitis vaccines: alternatives to production in mouse brain","volume":"10","author":"Halstead","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.01.054_bib0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1586\/erv.10.139","article-title":"IMOJEV((R)): a yellow fever virus-based novel Japanese encephalitis vaccine","volume":"9","author":"Appaiahgari","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"November (45)","key":"10.1016\/j.vaccine.2012.01.054_bib0045","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, September 2\u20133, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2012.01.054_bib0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1442-200X.1988.tb02516.x","article-title":"Japanese encephalitis vaccine","volume":"30","author":"Oya","year":"1988","journal-title":"Acta Paediatr Jpn"},{"issue":"May (Suppl. 2)","key":"10.1016\/j.vaccine.2012.01.054_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(00)00041-4","article-title":"Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains","volume":"18","author":"Kurane","year":"2000","journal-title":"Vaccine"},{"issue":"May (Suppl. 2)","key":"10.1016\/j.vaccine.2012.01.054_bib0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","article-title":"Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines","volume":"18","author":"Markoff","year":"2000","journal-title":"Vaccine"},{"issue":"July (29)","key":"10.1016\/j.vaccine.2012.01.054_bib0065","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1016\/j.vaccine.2007.05.034","article-title":"WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, June 1\u20132, 2006","volume":"25","author":"Ferguson","year":"2007","journal-title":"Vaccine"},{"issue":"August (35)","key":"10.1016\/j.vaccine.2012.01.054_bib0070","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.vaccine.2011.06.062","article-title":"Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO((R))) induced neutralizing antibody titers","volume":"29","author":"Van Gessel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.054_bib0075","unstructured":"WHO. World Health Organization Technical Report Series, No.771 Annex 6 Requirement for Japanese Encephalitis Vaccine (Inactivated) for Human Use 1988."},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.01.054_bib0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/JVI.45.1.124-132.1983","article-title":"Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies","volume":"45","author":"Kimura-Kuroda","year":"1983","journal-title":"J Virol"},{"issue":"December (Pt. 12)","key":"10.1016\/j.vaccine.2012.01.054_bib0085","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1099\/0022-1317-67-12-2663","article-title":"Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies","volume":"67","author":"Kimura-Kuroda","year":"1986","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T14:31:20Z","timestamp":1593613880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":17,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X12000928"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}